External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds

The use of epidermal growth factor receptor–targeting antibodies in metastatic colorectal cancer has been restricted to patients with wild-type KRAS tumors by the European Medicines Agency since 2008, based on data showing a lack of efficacy and potential harm in patients with mutant KRAS tumors. In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bellon, Ellen, Ligtenberg, Marjolijn J.L., Tejpar, Sabine, Cox, Karen, de Hertogh, Gert, de Stricker, Karin, Edsjö, Anders, Gorgoulis, Vassilis, Höfler, Gerald, Jung, Andreas, Kotsinas, Athanassios, Laurent-Puig, Pierre, López-Ríos, Fernando, Hansen, Tine Plato, Rouleau, Etienne, Vandenberghe, Peter, van Krieken, Johan J.M., Dequeker, Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228116/
https://ncbi.nlm.nih.gov/pubmed/21441573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0429
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados